Literature DB >> 15948435

Blood management in total joint arthroplasty.

Thomas P Sculco1, Andrea Baldini, E Michael Keating.   

Abstract

One of the primary goals in the perioperative care of orthopaedic patients undergoing surgery is the avoidance of allogeneic transfusion. There are a number of ways to lessen blood loss during surgical intervention including regional hypotensive anesthesia, careful and atraumatic surgical technique, and coagulation of bleeding surfaces. Achieving coagulation is difficult in spinal and arthroplasty procedures because of the large cancellous surfaces that are vascular and are not amenable to ligature or thermal coagulation. All measures of autologous blood salvage should be used including preoperative deposit of autologous blood, hemodilution techniques, intraoperative salvage (when appropriate), and postoperative retrieval and reinfusion. The use of perioperative recombinant erythropoietin is also a useful adjunct to promote stimulation of the bone marrow and increased red cell production. Although many infectious diseases that are transmitted through allogeneic blood transfusions have been lessened by better screening techniques, there is still potential life threatening reactions and viral transmissions that may be avoided by comprehensive blood management in joint arthroplasty.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15948435

Source DB:  PubMed          Journal:  Instr Course Lect        ISSN: 0065-6895


  8 in total

1.  Intravenous iron supplementation with intra-articular administration of tranexamic acid reduces the rate of allogeneic transfusions after simultaneous bilateral total knee arthroplasty.

Authors:  Dong Won Suh; Seung-Beom Han; Jong-Hoon Park; Kuhoang Cheong; Bong Soo Kyung
Journal:  Blood Transfus       Date:  2016-07-22       Impact factor: 3.443

Review 2.  Outpatient Total Joint Arthroplasty.

Authors:  Jack M Bert; Jessica Hooper; Sam Moen
Journal:  Curr Rev Musculoskelet Med       Date:  2017-12

3.  Testing the construct validity of hospital care quality indicators: a case study on hip replacement.

Authors:  Claudia Fischer; Hester F Lingsma; Helen A Anema; Job Kievit; Ewout W Steyerberg; Niek Klazinga
Journal:  BMC Health Serv Res       Date:  2016-10-05       Impact factor: 2.655

4.  Major Surgery in A Jehovah Witness with Sickle Cell Disease: Case Presentation.

Authors:  Udo Ego Anyaehie; Cajetan Uwatoronye Nwadinigwe; Arinze Duke Nwosu; Valentine Ogochukwu Ogbui
Journal:  J Orthop Case Rep       Date:  2016 Apr-Jun

5.  Predicting Factors for Allogeneic Blood Transfusion and Excessive Postoperative Blood Loss after Single Low-Dosage Intra-Articular Tranexamic Acid Application in Total Knee Replacement.

Authors:  Paphon Sa-Ngasoongsong; Siwadol Wongsak; Noratep Kulachote; Pongsthorn Chanplakorn; Patarawan Woratanarat; Viroj Kawinwonggowit
Journal:  Biomed Res Int       Date:  2017-02-26       Impact factor: 3.411

6.  Comparison of intravenous, topical or combined routes of tranexamic acid administration in patients undergoing total knee and hip arthroplasty: a meta-analysis of randomised controlled trials.

Authors:  Qi Sun; Jinyu Li; Jiang Chen; Chenying Zheng; Chuyin Liu; Yusong Jia
Journal:  BMJ Open       Date:  2019-01-28       Impact factor: 2.692

Review 7.  Peri-articular administration of tranexamic acid is an alternative route in total knee arthroplasty: a systematic review and meta-analysis.

Authors:  DingYuan Fan; Jia Ma; XiaoHua Liu; Lei Zhang
Journal:  J Orthop Surg Res       Date:  2022-04-07       Impact factor: 2.359

8.  Are reinfusion drains safe to use with periarticular liposomal bupivacaine? An analysis of systemic bupivacaine toxicity.

Authors:  Marc R Angerame; Gavin P Hart; Susan M Odum; Bryan D Springer
Journal:  Arthroplast Today       Date:  2017-08-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.